May 2nd 2025
Collagen structure and vessel density vary by photoaging type, highlighting the value of multimodal imaging in guiding individualized skin care strategies.
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Revolutionizing Atopic Dermatitis (RAD) Conference 2025
June 6-7, 2025
Register Now!
Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient
July 26, 2025
Register Now!
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis
View More
Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?
View More
Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management
View More
Burst CME: Targeted Therapy for Optimal Psoriasis Management
View More
Uplifting prize: UK lottery pays for surgery
February 1st 2007London - British surgeons have condemned a plastic surgery lottery that offers the winners money for facelifts, breast enlargements and tummy tucks. London-based Europa International is conducting what is thought to be the world's first lottery for cosmetic procedures.
Time will define Juvederm's place among HA fillers
January 1st 2007National report - Many in dermatology are anxiously anticipating the arrival of the latest addition to the hyaluronic acid filler market, Juvederm (Allergan Medical), as a new alternative to the long-held gold standard, Restylane (Medicis ?sthetics).
Combination treatment shows efficacy in facial hair removal
January 1st 2007National report - Laser photoepilation is considered the gold standard of treatment for the removal of unwanted facial hair in women. A recent study shows that combining eflornithine cream (Vaniqa, SkinMedica) with laser therapy can safely and effectively reduce the growth of hair as well as speed up the hair removal process, as compared to laser epilation therapy alone.
Combination treatment shows efficacy in facial hair removal
January 1st 2007National report - Laser photoepilation is considered the gold standard of treatment for the removal of unwanted facial hair in women. A recent study shows that combining eflornithine cream (Vaniqa, SkinMedica) with laser therapy can safely and effectively reduce the growth of hair as well as speed up the hair removal process, as compared to laser epilation therapy alone.
Time will define Juvederm's place among HA fillers
January 1st 2007National report - Many in dermatology are anxiously anticipating the arrival of the latest addition to the hyaluronic acid filler market, Juvederm (Allergan Medical), as a new alternative to the long-held gold standard, Restylane (Medicis ?sthetics).
Straight talk about cosmeceuticals
January 1st 2007New Orleans - The problem with today's cosmeceutical advertising is that it oversells the benefits of products in the marketplace, says Patricia K. Farris, M.D., a dermatologist who practices in New Orleans and is a clinical assistant professor in the department of dermatology at Tulane University.
New toxins: A perspective from two continents
January 1st 2007Palm Springs, Calif. - Botox (botulinum toxin type A, Allergan) offers patients with moderate-to-severe glabellar lines longer lasting efficacy and greater treatment satisfaction compared with those patients treated with Dysport (botulinum toxin type A, Ipsen Limited), according to one expert.